Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations [Phase 2]
A Phase 2 clinical trial evaluating olaparib in metastatic renal cell carcinoma patients with DNA repair gene mutations is currently recruit…
-
CLINICAL_TRIALS other · 2026-03-30Clinical Trial Update: Evaluation of a Simple-Prep Controlled Embolic [NA]
This clinical trial update indicates ongoing evaluation of a simple-prep controlled embolic device; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy [NA]
Clinical trial investigating ischemic preconditioning to reduce acute kidney injury after partial nephrectomy; the study is currently not ye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC [Phase 2]
This Phase 2 trial evaluates WGI-0301 in combination with nivolumab in patients with hepatocellular carcinoma and renal cell carcinoma. The …
-
EMA approval · 2026-03-26EMA Authorised: Kisplyx (lenvatinib mesilate) — Eisai GmbH
The European Medicines Agency authorised Kisplyx (lenvatinib mesilate) by Eisai GmbH for renal cell carcinoma. The decision included acceler…
-
EMA approval · 2026-03-25EMA Authorised: Zirabev (bevacizumab) — Pfizer Europe MA EEIG
Zirabev (bevacizumab) has been authorised by EMA for multiple cancer indications, including colorectal, breast, non-small cell lung, renal c…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II trial is evaluating the combination of Envafolimab (PD-L1 inhibitor) and lenvatinib in patients with solid tumors, including n…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for a combination of sasanlimab, palbociclib, and axitinib in metastatic renal cell carcinoma; currently recru…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma [EARLY_Phase 1]
This document reports an ongoing early-phase neoadjuvant trial of pembrolizumab and lenvatinib for renal cell carcinoma, with patient recrui…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer [NA]
A clinical trial evaluating an app-based mindfulness intervention to improve quality of life in patients with metastatic renal cell carcinom…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma [Phase 2]
This Phase 2 clinical trial update describes evaluating SBRT in combination with anlotinib and bimepolizumab for locally advanced or metasta…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study [Phase 2]
Phase II clinical trial evaluating AK112 (Yiwoxidan Anti) as monotherapy for metastatic clear cell renal cell carcinoma in patients intolera…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Drug Screening Using Novel IMD in Renal Cell Carcinoma [Phase 1]
This update notes an ongoing Phase 1 trial evaluating a novel investigational drug (Novel IMD) for renal cell carcinoma, with enrollment by …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC [Phase 2]
ClinicalTrials.gov update describes a Phase 2 neoadjuvant trial (NEOSHIFT-RCC) evaluating HIF-inhibitor immunotherapy for renal cell carcino…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers [NA]
A clinical trial update describing MRI functional imaging characteristics and fat quantification of CT-fat-free renal neoplasms and their re…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer [Phase 2]
A Phase 2 trial evaluating sitravatinib with nivolumab for advanced or metastatic clear cell renal cell carcinoma was terminated.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the combination of BGB-A445 with tislelizumab in patients with select advanced solid tumors, includ…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
A clinical trial is investigating whether Galectin-3 levels predict outcomes in patients with renal cell carcinoma, urothelial carcinoma, no…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy [NA]
Clinical trial update indicating ongoing recruitment for a study evaluating post-immunotherapy nephrectomy in metastatic renal cell carcinom…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03) [Phase 1, Phase 2]
This Phase 1/2 study evaluates combination therapies for renal cell carcinoma in patients with recurrent disease during or after anti-PD-(L)…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents [NA]
Clinical trial assessing whether MMP2 and MMP9 biomarker levels predict outcomes for patients with metastatic renal cell carcinoma treated w…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The NOTION study investigates in-home sampling of cytokines in cancer patients receiving immunotherapy, and the trial has completed. The con…